Nobori Dual Antiplatelet Therapy as Appropriate Duration | NCT01514227 | Trialant

Nobori Dual Antiplatelet Therapy as Appropriate Duration | NCT01514227 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Short-term DAPT (6 months) group	Experimental	6 months DAPT (aspirin and thienopyridine) prescription following Nobori stent	Drug: Aspirin or thienopyridine
Long-term DAPT (18 months) group	Experimental	18 months DAPT (aspirin and thienopyridine) prescription following Nobori stent	Drug: Aspirin and thienopyridine

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Aspirin or thienopyridine	Drug	Subjects randomized 6 month DAPT will be prescribed either aspirin or thienopyridine (clopidogrel or ticlopidine) following 6 months DAPT for the duration of study, which is left on the physician's discretion.

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Net adverse clinical and cerebral event (NACCE)	NACCE include all-cause death, non-fatal myocardial infarction, cerebrovascular events, and major bleeding.	18 months

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
28641838	Derived	Nakamura M, Iijima R, Ako J, Shinke T, Okada H, Ito Y, Ando K, Anzai H, Tanaka H, Ueda Y, Takiuchi S, Nishida Y, Ohira H, Kawaguchi K, Kadotani M, Niinuma H, Omiya K, Morita T, Zen K, Yasaka Y, Inoue K, Ishiwata S, Ochiai M, Hamasaki T, Yokoi H; NIPPON Investigators. Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1189-1198. doi: 10.1016/j.jcin.2017.04.019.

Condition Browse Module

Intervention Browse Module